Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: How to evaluate risk and when to implant a cardioverter- defibrillator?

Cardiology Journal

Volumn 16, Issue 6, 2009, Pages 588-591

  Woźniak, Olgierd ^a   Włodarska, Elzbieta Katarzyna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DESMOGLEIN 2; DESMOPLAKIN; DESMOSOMAL CADHERIN; SOTALOL; VERAPAMIL;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; DEFIBRILLATOR; DESMOSOME; ELECTROCARDIOGRAM; GENETIC VARIABILITY; HEART PROTECTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; PATIENT ASSESSMENT; PATIENT REFERRAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SUDDEN DEATH; TREATMENT PLANNING;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 74249102674     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Buja G, Estes NA 3rd, Wichter T, Corrado D, Marcus F, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Risk stratification and therapy. Prog Cardiovasc Dis, 2008; 50: 282-293.
2. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation, 2004; 110: 1879-1884.
3. Turrini P, Corrado D, Basso C, Nava A, Thiene G. Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol, 2003; 8: 161-169.
4. Włodarska EK. Analiza zwia̧zków miȩdzy patogennymi mutacjami genu koduja̧cego plakofilinȩ-2 z obrazem morfologicznym i przebiegiem klinicznym arytmogennej kardiomiopatii prawej komory. Rozprawa habilitacyjna. Instytut Kardiologii, Warszawa 2009.
5. Peters S. Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: Clues from long-term follow-up. Europace, 2008; 10: 816-820.
6. Corrado D, Leoni L, Link MS et al. Implantable cardioverter - defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation, 2003; 108: 3084-3091.
7. Wichter T, Paul M, Wollmann C et al. Implantable cardioverter// defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation, 2004; 109: 1503-1508.
8. Dalal D, Nasir K, Bomma C et al. Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation, 2005; 112: 3823-3832.
9. Piccini JP, Dalal D, Roguin A et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm, 2005; 2: 1188-1194.